Advanced Reliability Centered Maintenance Program for Major Pharmaceutical Company
Discover how we helped a major pharmaceutical company develop and implement advanced RCM programs.Read More
Pharmaceutical and Life Sciences
Reliable Solutions for Life Sciences
Our Asset Performance and Reliability practitioners apply a strategic approach to managing risk and utilize decades of EAM/CMMS implementation experience in Biotech, Medical Device and Pharmaceutical industries.
Go Beyond Reliability - Supporting Critical Infrastructure Worldwide
小蝌蚪视频 delivers data-driven solutions to help you eliminate uncertainty in your operations. Safety, risk and integrity management are at the core of what we do. 小蝌蚪视频 began providing non-classification marine technical services in 1971. Over the decades, our range of services expanded to support the diverse industrial and government clients that power, fuel and regulate our world.
Today, 小蝌蚪视频 provides data-driven risk and reliability solutions and technical services that help our clients confirm the safety, integrity, quality and environmental efficiency of their critical assets and operations.
Partnering for Success in Pharma 4.0
As the pharmaceutical industry continues to evolve and embrace the digital age, the concept of Pharma 4.0 has emerged as a driving force behind innovation, efficiency, and growth. At the heart of this transformation is the need for reliable, safe, and compliant operations that can meet the demands of a dynamic and complex market. However, achieving reliability in the context of Pharma 4.0 is no easy feat, as companies must navigate a range of challenges, from new technologies and processes to changing regulations and market pressures. That's where 小蝌蚪视频 comes in.
Our roadmap to reliability is designed to help companies succeed in Pharma 4.0 by providing innovative solutions, deep industry expertise, and a commitment to operational excellence.
Asset Reliability Services
We engineer asset reliability programs that maximize equipment life and minimize scheduled and unscheduled downtime. Explore our approach for optimizing asset performance using advanced technologies to build and maintain best-in-class Enterprise Asset Management (EAM) systems.
Enterprise Asset Management Solutions
Our comprehensive EAM strategy planning and process consulting include assessing your organization's current situation to identify areas for improvement and opportunities for return on investment and preparing multi-year asset performance management software and strategies.
Driving Regulatory Compliance
We understand how important it is to meet compliance requirements, implement a software validation lifecycle and maintain a validated state in the life sciences. Our goal is to help organizations maximize asset value and meet Code of Federal Regulations Title 21 Part 11 (21CFR11) guidelines and other compliance standards while applying advanced analytics for more strategic planning. Our capabilities include:
- Source Select Software (in compliance with 21CFR11)
- Software Configuration
- Validation Strategy
- Risk Analysis
- Authoring Validation Protocols
- Validation Protocols Execution (paper and electronic)
Webinar
How to Create a Holistic Reliability Strategy that Can Successfully Embrace Emerging Technology (IBM MAS)
We discuss how applying a holistic approach can ensure building a mature reliability program that is ready to embrace the technologies of Industry 4.0 and supported by the latest IBM MAS.
Project Profiles
Discover how we've helped clients bring novel concepts to market, optimize certification management programs, enhance safety performance and reduce risk.
Read More
Maximo EAM Implementation for Multinational Healthcare Manufacturing Facilities
Read how we produced a scalable upgrade platform and approach for IBM Maximo Asset Management.Read More
Evaluating Critical Asset Safeguards for Pharmaceutical Manufacturers
Learn how we provided a critical asset safeguard evaluation to support technical and operational excellence for a pharmaceutical company's manufacturing assets.Read More